RN7SL625P

Across TCGA pan-cancer cohorts, RN7SL625P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RN7SL625P’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where RN7SL625P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL625P is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

UCEC, LUAD, and LUSC are the cancer types where RN7SL625P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL625P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	III,IV	+0.301	.006	4	view →
LUAD	Female	II,III,IV	−0.156	.026	2	view →
LUSC	All	All	−0.064	.028	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RN7SL625P–UCEC

Open the UCEC breakdown →